Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
European Journal of Medicinal Chemistry
|
July 2, 2022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
Yuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Journal of the American Chemical Society
|
April 14, 2026
Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic Dyad
Sandeep Atla, Veerabhadra Vulupala, Yugendar R Alugubelli, et al.
Journal of Medicinal Chemistry
|
August 10, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
Zhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
Zhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2011
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies
Edmund C Lee, Michael Fitzgerald, Bret Bannerman, et al.
Antiviral Research
|
March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
Kaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Nature Communications
|
February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum
Kaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
Biorxiv : the Preprint Server for Biology
|
April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease
Kaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Chemmedchem
|
December 7, 2020
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Biorxiv : the Preprint Server for Biology
|
August 9, 2020
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
European Journal of Medicinal Chemistry
|
July 2, 2022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
Yuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Journal of the American Chemical Society
|
April 14, 2026
Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic Dyad
Sandeep Atla, Veerabhadra Vulupala, Yugendar R Alugubelli, et al.
Journal of Medicinal Chemistry
|
August 10, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
Zhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
Zhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2011
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies
Edmund C Lee, Michael Fitzgerald, Bret Bannerman, et al.
Antiviral Research
|
March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
Kaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Nature Communications
|
February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum
Kaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
Biorxiv : the Preprint Server for Biology
|
April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease
Kaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Chemmedchem
|
December 7, 2020
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Biorxiv : the Preprint Server for Biology
|
August 9, 2020
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors
Kai S Yang, Xinyu R Ma, Yuying Ma, et al.
Page
of 10